Equillium Stock Last Dividend Paid

EQ Stock

USD 0.77 0.01 1.28%

Equillium fundamentals help investors to digest information that contributes to Equillium's financial success or failures. It also enables traders to predict the movement of Equillium Stock. The fundamental analysis module provides a way to measure Equillium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Equillium stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Equillium Company Last Dividend Paid Analysis

Equillium's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Equillium Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Capital Surpluse	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Stock	Intangible Assets	Current Deferred Revenue
Total Assets		0.92	0.96	-0.87	-0.73	0.73	-0.38	0.65	0.9	0.55	0.76	-0.91	1.0	0.9	-0.85	0.81	0.52	0.69	0.8	0.29
Total Stockholder Equity	0.92		0.96	-0.71	-0.44	0.51	-0.34	0.56	0.75	0.24	0.8	-0.95	0.92	0.99	-0.82	0.59	0.19	0.43	0.64	0.02
Net Tangible Assets	0.96	0.96		-0.75	-0.6	0.62	-0.37	0.69	0.82	0.31	0.79	-0.97	0.96	0.92	-0.92	0.69	0.39	0.55	0.71	0.29
Net Debt	-0.87	-0.71	-0.75		0.79	-0.7	0.59	-0.55	-0.87	-0.72	-0.46	0.64	-0.86	-0.7	0.6	-0.82	-0.63	-0.76	-0.67	-0.26
Retained Earnings	-0.73	-0.44	-0.6	0.79		-0.9	0.37	-0.66	-0.89	-0.85	-0.33	0.49	-0.73	-0.39	0.66	-0.95	-0.94	-0.96	-0.85	-0.67
Accounts Payable	0.73	0.51	0.62	-0.7	-0.9		-0.48	0.7	0.9	0.82	0.56	-0.52	0.73	0.47	-0.67	0.96	0.85	0.94	0.89	0.48
Long Term Debt	-0.38	-0.34	-0.37	0.59	0.37	-0.48		-0.54	-0.42	-0.3	-0.42	0.25	-0.38	-0.27	0.31	-0.44	-0.45	-0.4	-0.14	-0.17
Long Term Debt Total	0.65	0.56	0.69	-0.55	-0.66	0.7	-0.54		0.69	0.34	0.53	-0.7	0.65	0.47	-0.85	0.66	0.63	0.57	0.66	0.57
Capital Surpluse	0.9	0.75	0.82	-0.87	-0.89	0.9	-0.42	0.69		0.74	0.55	-0.73	0.89	0.72	-0.79	0.97	0.71	0.91	0.93	0.36
Total Liab	0.55	0.24	0.31	-0.72	-0.85	0.82	-0.3	0.34	0.74		0.21	-0.2	0.55	0.26	-0.27	0.83	0.8	0.87	0.73	0.31
Net Invested Capital	0.76	0.8	0.79	-0.46	-0.33	0.56	-0.42	0.53	0.55	0.21		-0.79	0.77	0.79	-0.69	0.48	0.23	0.34	0.51	0.08
Short Long Term Debt	-0.91	-0.95	-0.97	0.64	0.49	-0.52	0.25	-0.7	-0.73	-0.2	-0.79		-0.91	-0.92	0.92	-0.58	-0.27	-0.42	-0.68	-0.23
Total Current Assets	1.0	0.92	0.96	-0.86	-0.73	0.73	-0.38	0.65	0.89	0.55	0.77	-0.91		0.9	-0.85	0.8	0.52	0.68	0.8	0.29
Net Working Capital	0.9	0.99	0.92	-0.7	-0.39	0.47	-0.27	0.47	0.72	0.26	0.79	-0.92	0.9		-0.75	0.56	0.12	0.4	0.63	-0.09
Short Term Debt	-0.85	-0.82	-0.92	0.6	0.66	-0.67	0.31	-0.85	-0.79	-0.27	-0.69	0.92	-0.85	-0.75		-0.7	-0.51	-0.58	-0.76	-0.51
Common Stock	0.81	0.59	0.69	-0.82	-0.95	0.96	-0.44	0.66	0.97	0.83	0.48	-0.58	0.8	0.56	-0.7		0.83	0.98	0.92	0.46
Property Plant Equipment	0.52	0.19	0.39	-0.63	-0.94	0.85	-0.45	0.63	0.71	0.8	0.23	-0.27	0.52	0.12	-0.51	0.83		0.88	0.67	0.79
Capital Stock	0.69	0.43	0.55	-0.76	-0.96	0.94	-0.4	0.57	0.91	0.87	0.34	-0.42	0.68	0.4	-0.58	0.98	0.88		0.87	0.51
Intangible Assets	0.8	0.64	0.71	-0.67	-0.85	0.89	-0.14	0.66	0.93	0.73	0.51	-0.68	0.8	0.63	-0.76	0.92	0.67	0.87		0.38
Current Deferred Revenue	0.29	0.02	0.29	-0.26	-0.67	0.48	-0.17	0.57	0.36	0.31	0.08	-0.23	0.29	-0.09	-0.51	0.46	0.79	0.51	0.38

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict Equillium

Equillium Dividends Paid

Dividends Paid

7.61 Million

At this time, Equillium's Dividends Paid is relatively stable compared to the past year.

Based on the recorded statements, Equillium has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Equillium Current Valuation Drivers

We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	58.7M	108.9M	108.6M	35.8M	25.1M	23.9M
Enterprise Value	55.2M	93.2M	68.2M	(13.2M)	2.7M	2.6M

Equillium Fundamentals

	Return On Equity	-0.34
	Return On Asset	-0.12
	Profit Margin	(0.20) %
	Operating Margin	(0.01) %
	Current Valuation	1.9 M
	Shares Outstanding	35.43 M
	Shares Owned By Insiders	36.20 %
	Shares Owned By Institutions	20.03 %
	Number Of Shares Shorted	153.57 K
	Price To Earning	(6.70) X
	Price To Book	1.18 X
	Price To Sales	0.64 X
	Revenue	36.08 M
	Gross Profit	15.76 M
	EBITDA	(12.14 M)
	Net Income	(13.34 M)
	Cash And Equivalents	57.56 M
	Cash Per Share	1.68 X
	Total Debt	824 K
	Debt To Equity	0.29 %
	Current Ratio	3.98 X
	Book Value Per Share	0.64 X
	Cash Flow From Operations	(21.78 M)
	Short Ratio	0.53 X
	Earnings Per Share	(0.12) X
	Target Price	3.33
	Number Of Employees	45
	Beta	1.83
	Market Capitalization	27.28 M
	Total Asset	50.53 M
	Retained Earnings	(185.74 M)
	Working Capital	21.78 M
	Current Asset	60.04 M
	Current Liabilities	1.81 M
	Net Asset	50.53 M

About Equillium Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

0.38	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.31	MNOV	MediciNova	Pair Corr

The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.

The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Equillium Stock Analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC